We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.13B
AUM Growth
-$145M
Cap. Flow
-$178M
Cap. Flow %
-8.34%
Top 10 Hldgs %
25.78%
Holding
1,594
New
34
Increased
419
Reduced
857
Closed
284

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$6.09M
2
AAPL icon
Apple
AAPL
+$5.83M
3
AMGN icon
Amgen
AMGN
+$5.16M
4
MSFT icon
Microsoft
MSFT
+$4.73M
5
ABBV icon
AbbVie
ABBV
+$4.26M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$5.44M
2
SLB icon
SLB Ltd
SLB
+$3.68M
3
FCX icon
Freeport-McMoran
FCX
+$3.13M
4
CVX icon
Chevron
CVX
+$2.97M
5
DUK icon
Duke Energy
DUK
+$2.44M

Sector Composition

Rank Sector Weight
1 Healthcare 31.2%
2 Technology 14.8%
3 Energy 7.96%
4 Financials 7.89%
5 Communication Services 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTR
1301
DELISTED
ENTROPIC COMMUNICATIONS INC COM STK (DE)
ENTR
$34K ﹤0.01%
12,838
-8,858
-41% -$25.3K
AOI
1302
DELISTED
Alliance One International
AOI
$24K ﹤0.01%
1,197
-842
-41% -$19.1K
FST
1303
DELISTED
FOREST OIL CORPORATION
FST
$21K ﹤0.01%
17,878
-12,353
-41% -$22.4K
DVAX
1304
DELISTED
Dynavax Technologies
DVAX
$19K ﹤0.01%
1,296
-1,368
-51% -$19.7K
RTK
1305
DELISTED
Rentech, Inc.
RTK
$18K ﹤0.01%
1,026
-1,083
-51% -$23.5K
LXRX icon
1306
Lexicon Pharmaceuticals
LXRX
$1.02B
$16K ﹤0.01%
1,659
-1,750
-51% -$18.7K
CGRN
1307
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$16K ﹤0.01%
76
-79
-51% -$20.2K
QMCO icon
1308
Quantum Corp
QMCO
$437M
$15K ﹤0.01%
79
-84
-52% -$16.7K
VTG
1309
DELISTED
VANTAGE DRILLING COMPANY ORD SHS (KY)
VTG
$13K ﹤0.01%
10,260
-10,830
-51% -$19.3K
AAON icon
1310
Aaon
AAON
$8.41B
-15,464
Closed -$230K
AAT
1311
American Assets Trust
AAT
$1.49B
-7,769
Closed -$268K
ABM icon
1312
ABM Industries
ABM
$2.8B
-10,891
Closed -$294K
ACLS icon
1313
Axcelis
ACLS
$4.12B
-3,608
Closed -$29K
ADEA icon
1314
Adeia
ADEA
$2.86B
-40,862
Closed -$239K
ADTN icon
1315
Adtran
ADTN
$798M
-13,523
Closed -$305K
AIN icon
1316
Albany International
AIN
$2.14B
-6,180
Closed -$235K
AIR icon
1317
AAR Corp
AIR
$5.15B
-7,802
Closed -$215K
APOG icon
1318
Apogee Enterprises
APOG
$850M
-7,390
Closed -$258K
ARCB icon
1319
ArcBest
ARCB
$3.44B
-5,664
Closed -$246K
EFOR
1320
Everforth Inc
EFOR
$845M
-11,640
Closed -$414K
AWR icon
1321
American States Water
AWR
$3.39B
-8,495
Closed -$282K
AXON
1322
Axon Enterprise
AXON
$40.5B
-13,746
Closed -$183K
AZTA icon
1323
Azenta
AZTA
$1.26B
-13,673
Closed -$147K
AZZ icon
1324
AZZ Inc
AZZ
$4.5B
-6,356
Closed -$293K
BCO icon
1325
Brink's
BCO
$5.02B
-9,992
Closed -$282K

Similar funds

Profund Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Profund Advisors held 1,594 positions worth $2.13B, down 6.4% from $2.28B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Profund Advisors withdrew a net $178M in Q3 2014, closing 284 positions and reducing 857 holdings. Its most notable exit was OPENTABLE,INC COMMON STOCK, an estimated $1.69M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 25% a quarter earlier, followed by Technology and Energy.

Against the trend, Profund Advisors opened a new position in Puma Biotechnology worth $3.06M.

  • Profund Advisors's largest Q3 2014 buy was Puma Biotechnology: 12,834 shares worth $3.06M.
  • Profund Advisors added most to Gilead Sciences in Q3 2014, an estimated $6.09M increase.
  • Profund Advisors's biggest Q3 2014 reduction was ExxonMobil, cutting an estimated $5.44M.
  • Profund Advisors fully exited OPENTABLE,INC COMMON STOCK in Q3 2014, selling an estimated $1.69M.
  • Profund Advisors's ten largest holdings make up 26% of its $2.13B portfolio in Q3 2014.
  • Profund Advisors opened 34 new positions and closed 284 in Q3 2014.
  • Profund Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.13B.

Based on Profund Advisors's 13F filing for Q3 2014, filed 6 Nov 2014.